Where does Kuros Biosurgery AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Kuros Biosurgery AG ranks #48,246 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Kuros Biosurgery AG hold?

Kuros Biosurgery AG holds 5 US utility patents granted between 2015 and 2022, spanning 7 technology areas.

What is Kuros Biosurgery AG's Innovation Score?

Kuros Biosurgery AG has an Innovation Score of 37.2 out of 100 (top 44% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Kuros Biosurgery AG's patent grant rate increasing or decreasing?

Kuros Biosurgery AG's recent grant velocity is -33% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Kuros Biosurgery AG's patents?

Kuros Biosurgery AG's patents average 28.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Kuros Biosurgery AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Kuros Biosurgery AG

Q: What technology areas does Kuros Biosurgery AG focus on?

Kuros Biosurgery AG's top technology area is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles) with 4 patents, ranking #808 of 2,589 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 7 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Kuros ranks #48,246 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 7 technology areas.

#48,246
of 49,997 US assignees by volume: Top 44%
by Innovation Score (37.2/100): 28.2
avg claims per patent: -33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R48246 · Foreign Corporation #48,246 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #48,246/49,997
PHOTO-FINISH Kukdong Jeyen
CPC-NARROW A61L · 7 areas
INNOV-THIN 37.2/100
CLAIMS-DENSE 28.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Kukdong Jeyen Company Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Kuros’s 37.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (17%) Velocity 6.7 pts (18%) Breadth 9.4 pts (25%) Claim depth 15.0 pts (40%)

Qualcomm Incorporated · highest

85
Kuros Biosurgery · this assignee

37
3D Lighting… · lowest

7

What this shows Kuros's Innovation Score is 37.2/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Kuros?

Each dot is one of Kuros’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Kuros’s own 28.2 claims/patent is ABOVE the 7.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Kuros vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Kuros's grants concentrate

Kuros Biosurgery AG is a focused PatentsView assignee: 7 CPC subclasses with 80% of grants classified under A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2016. By volume, Kuros sits between Kukdong Jeyen Company Limited and Kwatercraft Co., Ltd..

Kuros's three-year grant acceleration

Kuros Biosurgery AG shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Kukdong Jeyen

5
Kulr Technology

5
Kumonos

5
Kuraray Kuraflex

5
Kurosawa Construc…

5
Kurray

5
KVI

5
Kwatercraft

5
Kuros Biosurgery ◀

5

What this shows Kuros holds 5 patents at rank #48,158, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Kuros

By rank, the assignees closest to #48,158 in granted patent volume.

Leaders in A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…)

Other assignees with the most granted patents in Kuros's primary technology class.

Kuros's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 44% higher than 56% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Kuros Biosurgery AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	40.0%
2016	1	20.0%
2020	1	20.0%
2022	1	20.0%

Which technologies does Kuros Biosurgery AG patent most?

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 4

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

C08L - Compositions OF Macromolecular Compounds 2

B05C - Apparatus FOR Applying Fluent Materials TO Surfaces, IN General 1

A61C - DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Kuros Biosurgery AG's patent record in context - here's where to go next.

Kuros Biosurgery AG's lead technology class is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;), 80% of its portfolio - see every assignee active in that class. Explore A61L
Ranked #48,246 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Kuros Biosurgery AG against Kukdong Jeyen Company Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.